Pro-Dex, Inc.
PDEXNASDAQHealthcare● Active
$65.00
$-0.21(-0.32%)
Market Cap$207529400
P/E Ratio—
52W High$68.99
52W Low$23.47
Pro-Dex, Inc.（PDEX）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PDEX · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $7.16M | $6.85M | $4.07M | $1.60M | $1.60M |
| Net Receivables | $17.49M | $13.89M | $9.95M | $15.38M | $15.38M |
| Inventory | $22.21M | $15.27M | $16.17M | $12.68M | $12.68M |
| Total Current Assets | $47.30M | $36.61M | $30.98M | $31.17M | $31.17M |
| PP&E Net | $1.05M | $12.65M | $13.20M | $13.42M | $13.42M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.03M | $0.05M | $0.08M | $0.12M | $0.12M |
| Total Assets | $61.19M | $52.48M | $51.82M | $49.09M | $49.09M |
| Liabilities | |||||
| Short-Term Debt | $6.15M | $4.37M | $3.83M | $3.29M | $3.29M |
| Accounts Payable | $4.61M | $4.51M | $2.26M | $3.76M | $3.76M |
| Total Current Liabilities | $14.63M | $12.89M | $9.68M | $11.35M | $11.35M |
| Long-Term Debt | $9.25M | $7.54M | $8.91M | $10.25M | $10.25M |
| Total Liabilities | $24.56M | $21.61M | $20.23M | $23.66M | $23.66M |
| Stockholders Equity | |||||
| Retained Earnings | $35.93M | $26.95M | $24.82M | $17.75M | $17.75M |
| Total Stockholders Equity | $36.63M | $30.87M | $31.59M | $25.43M | $25.43M |
| Total Liab & Equity(computed) | $61.19M | $52.48M | $51.82M | $49.09M | $49.09M |
| Debt Summary | |||||
| Total Debt | $16.58M | $13.55M | $14.79M | $15.97M | $15.97M |
| Net Debt | $16.16M | $10.92M | $11.86M | $15.12M | $15.12M |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Pro-Dex, Inc.
关于Pro-Dex, Inc.（PDEX）资产负债表
Pro-Dex, Inc.总资产$0.06B，现金及短期投资$0.01B，总负债$0.02B，总债务$0.02B，股东权益$0.04B。
常见问题
PDEX · 4 问Pro-Dex, Inc.总债务$0.02B，净债务$0.02B。
PDEX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10